Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD

被引：360

作者：

Kuriyan, Ajay E. ^{[1
,3
]}

Albini, Thomas A. ^{[1
]}

Townsend, Justin H. ^{[1
]}

Rodriguez, Marianeli ^{[1
]}

Pandya, Hemang K. ^{[4
]}

Leonard, Robert E., II ^{[4
]}

Parrott, M. Brandon ^{[2
]}

Rosenfeld, Philip J. ^{[1
]}

Flynn, Harry W., Jr. ^{[1
]}

Goldberg, Jeffrey L. ^{[5
]}

机构：

[1] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA

[2] Ctr Sight, Sarasota, FL USA

[3] Univ Rochester, Med Ctr, Dept Ophthalmol, Flaum Eye Inst, Rochester, NY 14642 USA

[4] Univ Oklahoma, Dept Ophthalmol, Dean McGee Eye Inst, Oklahoma City, OK USA

[5] Stanford Univ, Byers Eye Inst, Dept Ophthalmol, Palo Alto, CA 94304 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 376卷 / 11期

基金：

美国国家卫生研究院;

关键词：

IN-VITRO DIFFERENTIATION; OPTIC-NERVE DISEASES; MACULAR DEGENERATION; OPHTHALMOLOGY TREATMENT; CLINICS; INTERVENTIONS; FDA; THERAPIES; SCOTS;

D O I：

10.1056/NEJMoa1609583

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Adipose tissue-derived "stem cells"have been increasingly used by "stem-cell clinics" in the United States and elsewhere to treat a variety of disorders. We evaluated three patients in whom severe bilateral visual loss developed after they received intravitreal injections of autologous adipose tissue-derived "stem cells"at one such clinic in the United States. In these three patients, the last documented visual acuity on the Snellen eye chart before the injection ranged from 20/30 to 20/200. The patients' severe visual loss after the injection was associated with ocular hypertension, hemorrhagic retinopathy, vitreous hemorrhage, combined traction and rhegmatogenous retinal detachment, or lens dislocation. After 1 year, the patients' visual acuity ranged from 20/200 to no light perception.

引用

页码：1047 / 1053

页数：7

共 24 条

[1]

Ambati, J ;

Ambati, BK ;

Yoo, SH ;

Ianchulev, S ;

Adamis, AP .

SURVEY OF OPHTHALMOLOGY, 2003, 48 (03) :257-293

[2]

Responsibilities of Health Care Professionals in Counseling and Educating PatientsWith Incurable Neurological Diseases Regarding "Stem Cell Tourism" Caveat Emptor [J].

Bowman, Michelle ;

Racke, Michael ;

Kissel, John ;

Imitola, Jaime .

JAMA NEUROLOGY, 2015, 72 (11) :1342-1345

[3]

Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature [J].

Falavarjani, K. Ghasemi ;

Nguyen, Q. D. .

EYE, 2013, 27 (07) :787-794

[4]

Francis PJ, 2010, INVEST OPHTH VIS SCI, V51

[5]

Ho AC, 2015, ANG EX DEG 2015 C MI

[6]

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss - AREDS Report No. 8 [J].

Kassoff, A ;

Kassoff, J ;

Buehler, J ;

Eglow, M ;

Kaufman, F ;

Mehu, M ;

Kieval, S ;

Mairs, M ;

Graig, B ;

Quattrocchi, A ;

Jones, D ;

Locatelli, J ;

Ruby, A ;

Capone, A ;

Garretson, B ;

Hassan, T ;

Trese, MT ;

Williams, GA ;

Regan, V ;

Manatrey, P ;

Streasick, P ;

Szydlowski, L ;

McIver, F ;

Bridges, C ;

Stanley, C ;

Cumming, K ;

Lewis, B ;

Zajechowski, M ;

Margherio, RR ;

Cox, MS ;

Camille, J ;

Falk, R ;

Siedlak, P ;

Neubert, C ;

Klein, ML ;

Stout, JT ;

O'Malley, A ;

Lauer, AK ;

Robertson, JE ;

Wilson, DJ ;

Beardsley, C ;

Anderson, H ;

Wallace, P ;

Smith, G ;

Howard, S ;

Dreyer, RF ;

Ma, C ;

Chenoweth, RG ;

Zilis, JD ;

Johnson, M .

ARCHIVES OF OPHTHALMOLOGY, 2001, 119 (10) :1417-1436

[7]

KLEIN R, 1992, OPHTHALMOLOGY, V99, P933

[8]

From bench to FDA to bedside: US regulatory trends for new stem cell therapies [J].

Knoepfler, Paul S. .

ADVANCED DRUG DELIVERY REVIEWS, 2015, 82-83 :192-196

[9]

Sources of retinal pigment epithelium (RPE) for replacement therapy [J].

Lee, E. ;

MacLaren, R. E. .

BRITISH JOURNAL OF OPHTHALMOLOGY, 2011, 95 (04) :445-449

[10]

In vitro Differentiation of Adult Adipose Mesenchymal Stem Cells into Retinal Progenitor Cells [J].

Moviglia, Gustavo A. ;

Blasetti, Nahuel ;

Zarate, Jorge O. ;

Pelayes, David E. .

OPHTHALMIC RESEARCH, 2012, 48 :1-5

← 1 2 3 →